SAN DIEGO--(BUSINESS WIRE)--Clarify Medical will feature the Clarify Medical Home Light Therapy System, its connected home phototherapy system for the treatment and monitoring of chronic skin conditions, at the Fall Clinical Dermatology Conference in Las Vegas, NV October 17-20.
The Clarify System, cleared by the FDA, is indicated for localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of targeted narrowband UVB (NB-UVB) light therapy; this helps to ensure that patients receive the proper doses recommended by the American Academy of Dermatology in its published Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis and The Vitiligo Working Group Recommendations for NarrowBand Ultraviolet B Light Phototherapy Treatment of Vitiligo.
The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress and satisfaction.
The Clarify smartphone app syncs to a patented, lightweight, handheld device which guides patients through delivering targeted narrowband UVB phototherapy treatments for their specific skin conditions. All treatment records, including photographs and patient-reported outcomes, are available to both the patient and the physician and can be used for evaluation during follow-up visits. Clarify CarePartners, trained patient support personnel, act as the first line of support for patients – coaching them on the use of the System and encouraging treatment adherence – greatly reducing the burden of these functions on the physician’s practice.
“The Clarify System solves problems that have prevented home phototherapy from being widely adopted by providing administrative and treatment controls, reducing the physician’s workload, and helping to ensure patient treatment adherence,” said George Mahaffey, President and CEO of Clarify Medical. “We’re excited to provide this innovative therapeutic delivery model to the medical dermatology community.”
Clarify will be demonstrating the Home Light Therapy System at the Fall Clinical Dermatology Conference at the Wynn Las Vegas October 17-20. Recently published real-world treatment adherence data will also be presented during a clinical poster session at the Conference.
About Clarify Medical, Inc.
Clarify Medical is a private San Diego-based medical device company focused on developing innovative technology, products and services that improve care for people with chronic skin conditions. Its Clarify Home Light Therapy System is now available nationally in the US. Learn more at www.clarifymed.com.